EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice

Saadet Turkseven, Cristian Turato iD, Gianmarco Villano, Mariagrazia Ruvoletto, Maria Guido, Massimo Bolognesi iD, Patrizia Pontisso, Marco Di Pascoli iD

Antioxidants · 21.04.2023 · 12 (4) · 971

DOI: 10.3390/antiox12040971 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 21.04.2023. Verfasst von Saadet Turkseven und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine-DIMED, University of Padova, 35100 Padova, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. NAFLD can evolve from simple fatty liver to non-alcoholic steatohepatitis (NASH), and ultimately, to cirrhosis. Inflammation and oxidative stress, promoted by mitochondrial dysfunction, play a crucial role in the onset and development of NASH. To date, no therapy has been approved for NAFLD and NASH. The aim of this study is to evaluate if the anti-inflammatory activity of acetylsalicylic acid (ASA) and the mitochondria-targeted antioxidant effect of mitoquinone could hinder the progression of non-alcoholic steatohepatitis. In mice, fatty liver was induced through the administration of a deficient in methionine and choline and rich in fat diet. Two experimental groups were treated orally with ASA or mitoquinone. Histopathologic evaluation of steatosis and inflammation was performed; the hepatic expression of genes associated with inflammation, oxidative stress, and fibrosis was evaluated; the protein expression of IL-10, cyclooxygenase 2, superoxide dismutase 1, and glutathione peroxidase 1 in the liver was analyzed; a quantitative analysis of 15-epi-lipoxin A4 in liver homogenates was performed. Mitoquinone and ASA significantly reduced liver steatosis and inflammation by decreasing the expression of TNFα, IL-6, Serpinb3, and cyclooxygenase 1 and 2 and restoring the anti-inflammatory IL-10. Treatment with mitoquinone and ASA increased the gene and protein expression of antioxidants, i.e., catalase, superoxide dismutase 1, and glutathione peroxidase 1, and decreased the expression of profibrogenic genes. ASA normalized the levels of 15-epi-Lipoxin A4. In mice fed with a deficient in methionine and choline and rich in fat diet, mitoquinone and ASA reduce steatosis and necroinflammation and may represent two effective novel strategies for the treatment of non-alcoholic steatohepatitis.

Schlagwörter

Stichwörter der Autor:innen

liver injurymitochondria dysfunctionoxidative stresssteatohepatitis

Autor:innen und Institutionen

  • Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine-DIMED, University of Padova, 35100 Padova, Italy.
  • Department of Pharmacology, Faculty of Pharmacy, Ege University, Izmir 35040, Turkey.
  • Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
  • Department of Surgical, Oncological and Gastroenterological Sciences-DISCOG, University of Padova, 35128 Padova, Italy.
  • Pathology ULSS2, Department of Medicine-DIMED, University of Padova, 31100 Treviso, Italy.

ORCID-Profile: Cristian Turato, Massimo Bolognesi, Marco Di Pascoli

Zitieren

APA

Turkseven, S., Turato, C., Villano, G., Ruvoletto, M., Guido, M., Bolognesi, M., Pontisso, P., & Di Pascoli, M. (2023). Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice. Antioxidants, 12(4), 971. https://doi.org/10.3390/antiox12040971

Vancouver

Turkseven S, Turato C, Villano G, Ruvoletto M, Guido M, Bolognesi M, et al. Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice. Antioxidants. 2023;12(4):971. doi:10.3390/antiox12040971

BibTeX
@article{Turkseven2023,
  author = {Turkseven, Saadet and Turato, Cristian and Villano, Gianmarco and Ruvoletto, Mariagrazia and Guido, Maria and Bolognesi, Massimo and Pontisso, Patrizia and Di Pascoli, Marco},
  title = {Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice},
  journal = {Antioxidants},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {971},
  doi = {10.3390/antiox12040971}
}
Kostenlos starten →